Latest Data & Signals Issued

Signal Type Signal Value Data
Score 0.000 125 days ( -74.40 % )
Last Price $172.36 0 %
High/ Low $172.36 - $172.36 0%
Chg 7 Days N/A $172.36 $172.36
Chg 30 Days N/A $172.36 $172.36
Chg 12 mos 373.78 % $36.38 $172.36
Trend - 3 mos N/A Width: 0 %
Trend - 12 mos 248.60 % Width: 37.01 %
Pred. range - 3 mos N/A - N/A -100.00 % - -100.00 %
Pred. range - 12 mos $574.85 - $787.60 233.52 % - 356.95 %
Short MA avg 3 mos Sell 0000-00-00 - N/A days
Long MA avg 3 mos Sell 0000-00-00 - N/A days
Short/Long MA avg 3 mos Sell 0000-00-00 - N/A days
Short MA avg 12 mos Sell 2023-07-25 - 107 days
Long MA avg 12 mos Buy 2023-02-28 - 208 days
Short/Long MA avg 12 mos Sell 0000-00-00 - N/A days
Pivot Short Sell 2023-12-21 - 2 days
Bollinger Sell 0000-00-00 - N/A days
MACD N/A No Dates Stored For This Signal
Click to get the best stock tips daily for free!

About RETA

RETA Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney disease (CKD) caused by Alport syndrome, as well as for a form of pulmonary arterial hypertension associated ... RETA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT